Crossmark

Evaluation of resistance mechanisms and susceptibility testing in Enterococcus spp.: implications of vancomycin-variable isolates and optrA-mediated resistance

Crossref DOI link: https://doi.org/10.1007/s10096-026-05556-8

Published Online: 2026-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Demir, Mervenur https://orcid.org/0000-0001-9229-0874
Ocaklı, Aylin İrem https://orcid.org/0000-0002-4829-1279
Tanrıverdi, Elif Seren https://orcid.org/0000-0002-0449-0356
Hazırolan, Gülşen https://orcid.org/0000-0003-4546-9729
Alp, Alpaslan https://orcid.org/0000-0001-7856-7590
Otlu, Barış https://orcid.org/0000-0002-6220-0521
Şener, Burçin https://orcid.org/0000-0002-0724-3166
Funding

Funding for this research was provided by:

Inonu University
License Information

Text and Data Mining valid from 2026-06-02

Version of Record valid from 2026-06-02
More Information

Article History

Received: 1 April 2026

Accepted: 25 May 2026

First Online: 2 June 2026

Declarations

:

: This study was approved by the Non-Interventional Clinical Research Ethics Board of Hacettepe University (Date: 20.04.2021, Decision No: 2021/09, GO 21/558).

: not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below